Fulcrum Therapeutics Announces Positive Interim Results from Pha

FULC: Fulcrum Therapeutics, Inc.
2021-08-10 07:00:00
Fulcrum Therapeutics Announces Positive Interim Results from Phase 1 Healthy Adult Volunteer Trial of FTX-6058 for Sickle Cell Disease